A customer reported a skin reaction with the adc device, with symptoms of itching, pain, purulence, and redness.The customer had contact with a healthcare professional and was prescribed unspecified medication for treatment.There was no report of death or permanent injury associated with this event.
|
Sensor (b)(4) has been returned and investigated.No physical damage observed on sensor patch.No issues were observed with the adhesive.The reported complaint is related to skin irritation or an allergic reaction to the patch adhesive of the freestyle libre sensor.Dhrs (device history record) for the freestyle libre sensor kit were reviewed, and the dhrs showed the freestyle libre sensor kit passed all tests prior to release.Dose audit reports were reviewed and demonstrates the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed, including bioburden and endotoxin testing, and demonstrated that all monitoring processes continue to meet adc minimum requirements for product quality.All pertinent information available to abbott diabetes care has been submitted.
|